In contrast, PLX4032 increased the levels of both p-ERK1/2 and DR5 in the tested cancer cell lines harboring either mutant K-Ras or N-Ras (H1299), whereas AZD6244 was still effective in suppressing ERK phosphorylation and DR5 expression (Fig. 1B). The gene discussed is NRAS; the disease is cancer.